Union Funds Exit Amgen, Teva Antitrust MDL
By Nadia Dreid · January 10, 2024, 10:18 PM EST
Teva Pharmaceuticals has settled its differences with the union funds making up the indirect purchase class in multidistrict litigation accusing it of hatching an illegal deal to remove a generic calcium-control...
To view the full article, register now.